Tel: 01789 267520

European Medicines Agency (EMA) report on Spinraza

27 June 2017

You can now read the detailed science behind the European Commission decision to authorise the marketing of nusinersen in Europe. This 117-page-long report includes full details of the various clinical trials there have been.

Read more